Loading…
Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice
Dendritic cells (DC) are highly efficient at inducing primary T cell responses. Consequently, DC are being investigated for their potential to prevent and/or treat human immunodeficiency virus type 1 (HIV-1) infection. In the current study, we examined the capacity of DC to elicit CD8 super(+) cytot...
Saved in:
Published in: | Clinical immunology (Orlando, Fla.) Fla.), 2001-10, Vol.101 (1), p.51-58 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 58 |
container_issue | 1 |
container_start_page | 51 |
container_title | Clinical immunology (Orlando, Fla.) |
container_volume | 101 |
creator | Abdel-Motal, U M Friedline, R Poligone, B Pogue-Caley, R R Frelinger, JA Tisch, R |
description | Dendritic cells (DC) are highly efficient at inducing primary T cell responses. Consequently, DC are being investigated for their potential to prevent and/or treat human immunodeficiency virus type 1 (HIV-1) infection. In the current study, we examined the capacity of DC to elicit CD8 super(+) cytotoxic T lymphocyte (CTL) reactivity against an HLA-A*0201-restricted HIV-1 reverse transcriptase (pol) epitope (residues 476-484) and two naturally occurring variants. Previous work demonstrated that the wild-type pol epitope is recognized by CTLs from HIV-1-infected individuals, whereas the variant pol epitopes are not, despite binding to HLA-A*0201. In agreement with these observations, parenteral administration of wild-type pol peptide induced HLA-A*0201-restricted CTL activity in A2K super(b) transgenic mice. In contrast, similar treatment with the two variant pol peptides failed to stimulate CTL reactivity, and this lack of immunogenicity correlated with reduced peptide:HLA-A*0201 complex stability. However, CTL responses were induced in A2K super(b) transgenic mice upon adoptive transfer of syngeneic bone marrow DC pulsed with the variant pol peptides. Furthermore, DC pulsed with the wild-type pol peptide elicited CTLs that cross-reacted with the variant pol epitopes. These results demonstrate that DC effectively expand the T cell repertoire of a given epitope to include cross-reactive T cell clonotypes. Accordingly, DC vaccination may aid in immune recognition of HIV-1 escape variants by broadening the T cell response. |
doi_str_mv | 10.1006/clim.2001.5095 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_18351373</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18351373</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_183513733</originalsourceid><addsrcrecordid>eNqNj7tOxDAQRV2AxPJoqadCUGTXTpQA5SosCmKhgGgpV8aZwKDENn4g8on8FQbxAVRXGt1zRpexY8HngvNqoQYa5znnYl7yy3KHzUSZi6yqRLXH9r1_45yXeV7N2NcV6s5RIAU1DgNspFKkZSCj4UZ3UaGH2hnvsweUKtAHQj0FE8xnIlpYT6N9NWoKqfZoUVGfzr1x8ERDl7WTRZC6g3sZopM_dkdSB2jiKJN_HKM2HSaGUKsJNuSih19KwMpSMDZ5SUOzXmZLnnOxuAUfLbrT5zNondT-BXX6eEcKD9luLwePR395wE6uV23dZNaZ94g-bEfyKm2UGk30W3FRlKI4L4p_F78BlgtxDg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18351373</pqid></control><display><type>article</type><title>Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice</title><source>ScienceDirect Journals</source><creator>Abdel-Motal, U M ; Friedline, R ; Poligone, B ; Pogue-Caley, R R ; Frelinger, JA ; Tisch, R</creator><creatorcontrib>Abdel-Motal, U M ; Friedline, R ; Poligone, B ; Pogue-Caley, R R ; Frelinger, JA ; Tisch, R</creatorcontrib><description>Dendritic cells (DC) are highly efficient at inducing primary T cell responses. Consequently, DC are being investigated for their potential to prevent and/or treat human immunodeficiency virus type 1 (HIV-1) infection. In the current study, we examined the capacity of DC to elicit CD8 super(+) cytotoxic T lymphocyte (CTL) reactivity against an HLA-A*0201-restricted HIV-1 reverse transcriptase (pol) epitope (residues 476-484) and two naturally occurring variants. Previous work demonstrated that the wild-type pol epitope is recognized by CTLs from HIV-1-infected individuals, whereas the variant pol epitopes are not, despite binding to HLA-A*0201. In agreement with these observations, parenteral administration of wild-type pol peptide induced HLA-A*0201-restricted CTL activity in A2K super(b) transgenic mice. In contrast, similar treatment with the two variant pol peptides failed to stimulate CTL reactivity, and this lack of immunogenicity correlated with reduced peptide:HLA-A*0201 complex stability. However, CTL responses were induced in A2K super(b) transgenic mice upon adoptive transfer of syngeneic bone marrow DC pulsed with the variant pol peptides. Furthermore, DC pulsed with the wild-type pol peptide elicited CTLs that cross-reacted with the variant pol epitopes. These results demonstrate that DC effectively expand the T cell repertoire of a given epitope to include cross-reactive T cell clonotypes. Accordingly, DC vaccination may aid in immune recognition of HIV-1 escape variants by broadening the T cell response.</description><identifier>ISSN: 1521-6616</identifier><identifier>DOI: 10.1006/clim.2001.5095</identifier><language>eng</language><subject>histocompatibility antigen HLA ; Human immunodeficiency virus 1</subject><ispartof>Clinical immunology (Orlando, Fla.), 2001-10, Vol.101 (1), p.51-58</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Abdel-Motal, U M</creatorcontrib><creatorcontrib>Friedline, R</creatorcontrib><creatorcontrib>Poligone, B</creatorcontrib><creatorcontrib>Pogue-Caley, R R</creatorcontrib><creatorcontrib>Frelinger, JA</creatorcontrib><creatorcontrib>Tisch, R</creatorcontrib><title>Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice</title><title>Clinical immunology (Orlando, Fla.)</title><description>Dendritic cells (DC) are highly efficient at inducing primary T cell responses. Consequently, DC are being investigated for their potential to prevent and/or treat human immunodeficiency virus type 1 (HIV-1) infection. In the current study, we examined the capacity of DC to elicit CD8 super(+) cytotoxic T lymphocyte (CTL) reactivity against an HLA-A*0201-restricted HIV-1 reverse transcriptase (pol) epitope (residues 476-484) and two naturally occurring variants. Previous work demonstrated that the wild-type pol epitope is recognized by CTLs from HIV-1-infected individuals, whereas the variant pol epitopes are not, despite binding to HLA-A*0201. In agreement with these observations, parenteral administration of wild-type pol peptide induced HLA-A*0201-restricted CTL activity in A2K super(b) transgenic mice. In contrast, similar treatment with the two variant pol peptides failed to stimulate CTL reactivity, and this lack of immunogenicity correlated with reduced peptide:HLA-A*0201 complex stability. However, CTL responses were induced in A2K super(b) transgenic mice upon adoptive transfer of syngeneic bone marrow DC pulsed with the variant pol peptides. Furthermore, DC pulsed with the wild-type pol peptide elicited CTLs that cross-reacted with the variant pol epitopes. These results demonstrate that DC effectively expand the T cell repertoire of a given epitope to include cross-reactive T cell clonotypes. Accordingly, DC vaccination may aid in immune recognition of HIV-1 escape variants by broadening the T cell response.</description><subject>histocompatibility antigen HLA</subject><subject>Human immunodeficiency virus 1</subject><issn>1521-6616</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqNj7tOxDAQRV2AxPJoqadCUGTXTpQA5SosCmKhgGgpV8aZwKDENn4g8on8FQbxAVRXGt1zRpexY8HngvNqoQYa5znnYl7yy3KHzUSZi6yqRLXH9r1_45yXeV7N2NcV6s5RIAU1DgNspFKkZSCj4UZ3UaGH2hnvsweUKtAHQj0FE8xnIlpYT6N9NWoKqfZoUVGfzr1x8ERDl7WTRZC6g3sZopM_dkdSB2jiKJN_HKM2HSaGUKsJNuSih19KwMpSMDZ5SUOzXmZLnnOxuAUfLbrT5zNondT-BXX6eEcKD9luLwePR395wE6uV23dZNaZ94g-bEfyKm2UGk30W3FRlKI4L4p_F78BlgtxDg</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Abdel-Motal, U M</creator><creator>Friedline, R</creator><creator>Poligone, B</creator><creator>Pogue-Caley, R R</creator><creator>Frelinger, JA</creator><creator>Tisch, R</creator><scope>7T5</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20011001</creationdate><title>Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice</title><author>Abdel-Motal, U M ; Friedline, R ; Poligone, B ; Pogue-Caley, R R ; Frelinger, JA ; Tisch, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_183513733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>histocompatibility antigen HLA</topic><topic>Human immunodeficiency virus 1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abdel-Motal, U M</creatorcontrib><creatorcontrib>Friedline, R</creatorcontrib><creatorcontrib>Poligone, B</creatorcontrib><creatorcontrib>Pogue-Caley, R R</creatorcontrib><creatorcontrib>Frelinger, JA</creatorcontrib><creatorcontrib>Tisch, R</creatorcontrib><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Clinical immunology (Orlando, Fla.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abdel-Motal, U M</au><au>Friedline, R</au><au>Poligone, B</au><au>Pogue-Caley, R R</au><au>Frelinger, JA</au><au>Tisch, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice</atitle><jtitle>Clinical immunology (Orlando, Fla.)</jtitle><date>2001-10-01</date><risdate>2001</risdate><volume>101</volume><issue>1</issue><spage>51</spage><epage>58</epage><pages>51-58</pages><issn>1521-6616</issn><abstract>Dendritic cells (DC) are highly efficient at inducing primary T cell responses. Consequently, DC are being investigated for their potential to prevent and/or treat human immunodeficiency virus type 1 (HIV-1) infection. In the current study, we examined the capacity of DC to elicit CD8 super(+) cytotoxic T lymphocyte (CTL) reactivity against an HLA-A*0201-restricted HIV-1 reverse transcriptase (pol) epitope (residues 476-484) and two naturally occurring variants. Previous work demonstrated that the wild-type pol epitope is recognized by CTLs from HIV-1-infected individuals, whereas the variant pol epitopes are not, despite binding to HLA-A*0201. In agreement with these observations, parenteral administration of wild-type pol peptide induced HLA-A*0201-restricted CTL activity in A2K super(b) transgenic mice. In contrast, similar treatment with the two variant pol peptides failed to stimulate CTL reactivity, and this lack of immunogenicity correlated with reduced peptide:HLA-A*0201 complex stability. However, CTL responses were induced in A2K super(b) transgenic mice upon adoptive transfer of syngeneic bone marrow DC pulsed with the variant pol peptides. Furthermore, DC pulsed with the wild-type pol peptide elicited CTLs that cross-reacted with the variant pol epitopes. These results demonstrate that DC effectively expand the T cell repertoire of a given epitope to include cross-reactive T cell clonotypes. Accordingly, DC vaccination may aid in immune recognition of HIV-1 escape variants by broadening the T cell response.</abstract><doi>10.1006/clim.2001.5095</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1521-6616 |
ispartof | Clinical immunology (Orlando, Fla.), 2001-10, Vol.101 (1), p.51-58 |
issn | 1521-6616 |
language | eng |
recordid | cdi_proquest_miscellaneous_18351373 |
source | ScienceDirect Journals |
subjects | histocompatibility antigen HLA Human immunodeficiency virus 1 |
title | Dendritic Cell Vaccination Induces Cross-Reactive Cytotoxic T Lymphocytes Specific for Wild-Type and Natural Variant Human Immunodeficiency Virus Type 1 Epitopes in HLA-A0201/K super(b) Transgenic Mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dendritic%20Cell%20Vaccination%20Induces%20Cross-Reactive%20Cytotoxic%20T%20Lymphocytes%20Specific%20for%20Wild-Type%20and%20Natural%20Variant%20Human%20Immunodeficiency%20Virus%20Type%201%20Epitopes%20in%20HLA-A0201/K%20super(b)%20Transgenic%20Mice&rft.jtitle=Clinical%20immunology%20(Orlando,%20Fla.)&rft.au=Abdel-Motal,%20U%20M&rft.date=2001-10-01&rft.volume=101&rft.issue=1&rft.spage=51&rft.epage=58&rft.pages=51-58&rft.issn=1521-6616&rft_id=info:doi/10.1006/clim.2001.5095&rft_dat=%3Cproquest%3E18351373%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_183513733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18351373&rft_id=info:pmid/&rfr_iscdi=true |